These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21203912)

  • 1. Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kanai Y; Shiozawa T; Tonegawa S; Konishi I
    Protein Cell; 2010 Aug; 1(8):711-7. PubMed ID: 21203912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kanai Y; Shiozawa T; Tonegawa S; Konishi I
    Sarcoma; 2011; 2011():476498. PubMed ID: 21437229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POTENTIAL DIAGNOSTIC BIOMARKERS FOR HUMAN MESENCHYMAL TUMORS, ESPECIALLY LMP2/Β1I AND CYCLIN E1/MIB1 DIFFERENTIAL EXPRESSION: PRUM-IBIO STUDY.
    Tanabe Y; Hayashi T; Okada M; Aburatani H; Tonegawa S; Abiko K; Konishi I
    Georgian Med News; 2024 May; (350):42-48. PubMed ID: 39089269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
    Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Leiomyosarcoma Tumorigenesis in Lmp2-deficient Mice: Involvement of Impaired Anti-oncogenic Factor IRF1.
    Hayashi T; Horiuchi A; Sano K; Yaegashi N; Konishi I
    Anticancer Res; 2015 Sep; 35(9):4665-79. PubMed ID: 26254356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kasai M; Ichimura T; Sudo T; Tagawa Y; Nishimura R; Ishiko O; Kanai Y; Yaegashi N; Aburatani H; Shiozawa T; Konishi I
    Sci Rep; 2011; 1():180. PubMed ID: 22355695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kasai M; Ichimura T; Nagase S; Ishiko O; Shiozawa T; Kanai Y; Yaegashi N; Aburatani H; Tonegawa S; Konishi I
    N Am J Med Sci; 2011 Sep; 3(9):394-9. PubMed ID: 22362447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: morphological significance of calponin h1.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kasai M; Ichimura T; Sudo T; Nishimura R; Ishiko O; Shiozawa T; Kanai Y; Yaegashi N; Aburatani H; Konishi I
    FEBS Lett; 2012 Jun; 586(13):1824-31. PubMed ID: 22659265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
    Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
    J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
    Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
    Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.
    Zhang Q; Ubago J; Li L; Guo H; Liu Y; Qiang W; Kim JJ; Kong B; Wei JJ
    Cancer; 2014 Oct; 120(20):3165-77. PubMed ID: 24986214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma.
    Hayashi T; Kawano M; Ichimura T; Ida K; Ando H; Zharhary D; Kanai Y; Aburatani H; Tonegawa S; Shiozawa T; Yaegashi N; Konishi I
    Anticancer Res; 2016 Oct; 36(10):4997-5007. PubMed ID: 27798858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
    Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
    Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
    Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
    Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Leiomyosarcoma: Induction of Hematogenous Metastasis by Isolated Uterine Mesenchymal Tumor Stem-like Cells.
    Hayashi T; Sano K; Ichimura T; Kanai Y; Zharhary D; Aburatani H; Yaegashi N; Konishi I
    Anticancer Res; 2020 Mar; 40(3):1255-1265. PubMed ID: 32132022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression.
    Hayashi T; Shimamura Y; Saegusa T; Horiuchi A; Kobayashi Y; Hiraoka N; Kanai Y; Aburatani H; Sano K; Konishi I
    Gene Regul Syst Bio; 2008 Jul; 2():297-305. PubMed ID: 19787091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells.
    Garcia N; Al-Hendy A; Baracat EC; Carvalho KC; Yang Q
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.